Literature DB >> 28279644

Elderly Patient-Derived Endothelial Cells for Vascularization of Engineered Muscle.

Luba Perry1, Moshe Y Flugelman2, Shulamit Levenberg3.   

Abstract

In vitro prevascularization of engineered tissue constructs promises to enhance their clinical applicability. We hypothesize that adult endothelial cells (ECs), isolated from limb veins of elderly patients, bear the vasculogenic properties required to form vascular networks in vitro that can later integrate with the host vasculature upon implantation. Here, we show that adult ECs formed vessel networks that were more developed and complex than those formed by human umbilical vein endothelial cells (HUVECs) seeded with various supporting cells on three-dimensional (3D) biodegradable polymer scaffolds. In parallel, secreted levels of key proangiogenic cytokines were significantly higher in adult EC-bearing scaffolds as compared to HUVEC scaffolds. As a proof of concept for applicability of this model, adult ECs were co-seeded with human myoblasts as well as supporting cells and successfully formed a branched network, which was surrounded by aligned human myotubes. The vascularized engineered muscle tissue implanted into a full-thickness defect in immunodeficient mice remained viable and anastomosed with the host vasculature within 9 days of implantation. Functional "chimeric" blood vessels and various types of anastomosis were observed. These findings provide strong evidence of the applicability of adult ECs in construction of clinically relevant autologous vascularized tissue.
Copyright © 2017 The American Society of Gene and Cell Therapy. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  cell therapy; endothelial cells; neovascularization; tissue engineering

Mesh:

Substances:

Year:  2017        PMID: 28279644      PMCID: PMC5383646          DOI: 10.1016/j.ymthe.2017.02.011

Source DB:  PubMed          Journal:  Mol Ther        ISSN: 1525-0016            Impact factor:   11.454


  37 in total

1.  Co-expression of fibulin-5 and VEGF165 increases long-term patency of synthetic vascular grafts seeded with autologous endothelial cells.

Authors:  M Preis; J Schneiderman; B Koren; Y Ben-Yosef; D Levin-Ashkenazi; S Shapiro; T Cohen; M Blich; M Israeli-Amit; Y Sarnatzki; D Gershtein; R Shofti; B S Lewis; Y Shaul; M Y Flugelman
Journal:  Gene Ther       Date:  2015-12-24       Impact factor: 5.250

2.  In vivo vasculogenic potential of human blood-derived endothelial progenitor cells.

Authors:  Juan M Melero-Martin; Zia A Khan; Arnaud Picard; Xiao Wu; Sailaja Paruchuri; Joyce Bischoff
Journal:  Blood       Date:  2007-02-27       Impact factor: 22.113

3.  Rapid anastomosis of endothelial progenitor cell-derived vessels with host vasculature is promoted by a high density of cotransplanted fibroblasts.

Authors:  Xiaofang Chen; Anna S Aledia; Stephanie A Popson; Linda Him; Christopher C W Hughes; Steven C George
Journal:  Tissue Eng Part A       Date:  2010-02       Impact factor: 3.845

4.  Engineered blood vessel networks connect to host vasculature via wrapping-and-tapping anastomosis.

Authors:  Gang Cheng; Shan Liao; Hon Kit Wong; Delphine A Lacorre; Emmanuelle di Tomaso; Patrick Au; Dai Fukumura; Rakesh K Jain; Lance L Munn
Journal:  Blood       Date:  2011-08-11       Impact factor: 22.113

Review 5.  The pivotal role of vascularization in tissue engineering.

Authors:  François A Auger; Laure Gibot; Dan Lacroix
Journal:  Annu Rev Biomed Eng       Date:  2013-08-29       Impact factor: 9.590

6.  Morphogenesis of 3D vascular networks is regulated by tensile forces.

Authors:  Dekel Rosenfeld; Shira Landau; Yulia Shandalov; Noa Raindel; Alina Freiman; Erez Shor; Yaron Blinder; Herman H Vandenburgh; David J Mooney; Shulamit Levenberg
Journal:  Proc Natl Acad Sci U S A       Date:  2016-03-07       Impact factor: 11.205

7.  Genetically engineered endothelial cells remain adherent and viable after stent deployment and exposure to flow in vitro.

Authors:  M Y Flugelman; R Virmani; M B Leon; R L Bowman; D A Dichek
Journal:  Circ Res       Date:  1992-02       Impact factor: 17.367

8.  Angiopoietin-2 differentially regulates angiogenesis through TIE2 and integrin signaling.

Authors:  Moritz Felcht; Robert Luck; Alexander Schering; Philipp Seidel; Kshitij Srivastava; Junhao Hu; Arne Bartol; Yvonne Kienast; Christiane Vettel; Elias K Loos; Simone Kutschera; Susanne Bartels; Sila Appak; Eva Besemfelder; Dorothee Terhardt; Emmanouil Chavakis; Thomas Wieland; Christian Klein; Markus Thomas; Akiyoshi Uemura; Sergij Goerdt; Hellmut G Augustin
Journal:  J Clin Invest       Date:  2012-05-15       Impact factor: 14.808

9.  A new approach to tissue engineering of vascularized skeletal muscle.

Authors:  A D Bach; A Arkudas; J Tjiawi; E Polykandriotis; U Kneser; R E Horch; J P Beier
Journal:  J Cell Mol Med       Date:  2006 Jul-Sep       Impact factor: 5.310

10.  Mesenchymal stem cells induce endothelial cell quiescence and promote capillary formation.

Authors:  Torbjorn O Pedersen; Anna L Blois; Ying Xue; Zhe Xing; Yang Sun; Anna Finne-Wistrand; James B Lorens; Inge Fristad; Knut N Leknes; Kamal Mustafa
Journal:  Stem Cell Res Ther       Date:  2014-02-17       Impact factor: 6.832

View more
  15 in total

1.  Improved Patency of ePTFE Grafts as a Hemodialysis Access Site by Seeding Autologous Endothelial Cells Expressing Fibulin-5 and VEGF.

Authors:  Itai Tzchori; Mizied Falah; Denis Shteynberg; Dana Levin Ashkenazi; Zeev Loberman; Luba Perry; Moshe Y Flugelman
Journal:  Mol Ther       Date:  2018-04-05       Impact factor: 11.454

Review 2.  Vascularized microfluidic organ-chips for drug screening, disease models and tissue engineering.

Authors:  Tatsuya Osaki; Vivek Sivathanu; Roger D Kamm
Journal:  Curr Opin Biotechnol       Date:  2018-04-12       Impact factor: 9.740

3.  Mature vessel networks in engineered tissue promote graft-host anastomosis and prevent graft thrombosis.

Authors:  Shahar Ben-Shaul; Shira Landau; Uri Merdler; Shulamit Levenberg
Journal:  Proc Natl Acad Sci U S A       Date:  2019-02-04       Impact factor: 11.205

4.  Electrospun Microvasculature for Rapid Vascular Network Restoration.

Authors:  Je-Hyun Han; Ung Hyun Ko; Hyo Jun Kim; Seunggyu Kim; Jessie S Jeon; Jennifer H Shin
Journal:  Tissue Eng Regen Med       Date:  2020-09-10       Impact factor: 4.169

Review 5.  Bioprinting Approaches to Engineering Vascularized 3D Cardiac Tissues.

Authors:  Nazan Puluca; Soah Lee; Stefanie Doppler; Andrea Münsterer; Martina Dreßen; Markus Krane; Sean M Wu
Journal:  Curr Cardiol Rep       Date:  2019-07-27       Impact factor: 2.931

Review 6.  Modulation of the Immune System Promotes Tissue Regeneration.

Authors:  Masoomeh Masoomikarimi; Majid Salehi
Journal:  Mol Biotechnol       Date:  2022-01-13       Impact factor: 2.695

Review 7.  Vascularized and Innervated Skeletal Muscle Tissue Engineering.

Authors:  Jordana Gilbert-Honick; Warren Grayson
Journal:  Adv Healthc Mater       Date:  2019-10-17       Impact factor: 9.933

Review 8.  Engineering skeletal muscle: Building complexity to achieve functionality.

Authors:  Eszter Mihaly; Dallas E Altamirano; Sami Tuffaha; Warren Grayson
Journal:  Semin Cell Dev Biol       Date:  2021-05-11       Impact factor: 7.499

9.  Three-Dimensional Human iPSC-Derived Artificial Skeletal Muscles Model Muscular Dystrophies and Enable Multilineage Tissue Engineering.

Authors:  Sara Martina Maffioletti; Shilpita Sarcar; Alexander B H Henderson; Ingra Mannhardt; Luca Pinton; Louise Anne Moyle; Heather Steele-Stallard; Ornella Cappellari; Kim E Wells; Giulia Ferrari; Jamie S Mitchell; Giulia E Tyzack; Vassilios N Kotiadis; Moustafa Khedr; Martina Ragazzi; Weixin Wang; Michael R Duchen; Rickie Patani; Peter S Zammit; Dominic J Wells; Thomas Eschenhagen; Francesco Saverio Tedesco
Journal:  Cell Rep       Date:  2018-04-17       Impact factor: 9.423

10.  Genetically engineered human muscle transplant enhances murine host neovascularization and myogenesis.

Authors:  Luba Perry; Shira Landau; Moshe Y Flugelman; Shulamit Levenberg
Journal:  Commun Biol       Date:  2018-10-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.